Caricamento...
LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2
BACKGROUND: Mantle cell lymphoma (MCL) is considered an aggressive subtype of non-Hodgkin’s lymphoma with variable treatment responses. There is an urgent need to identify novel markers with prognostic and therapeutic value for MCL. Long non-coding RNAs (lncRNAs) have emerged as key regulators in ca...
Salvato in:
| Pubblicato in: | J Transl Med |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5175387/ https://ncbi.nlm.nih.gov/pubmed/27998273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-016-1100-9 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|